So Yamaguchi

Title: So Yamaguchi: Innovator in Antibody Formulations

Introduction

So Yamaguchi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibody formulations. With a total of 3 patents to his name, Yamaguchi's work focuses on innovative solutions for stabilizing and administering antibodies.

Latest Patents

Yamaguchi's latest patents include formulations containing anti-IL-31RA antibodies. One of his notable inventions is a lyophilized formulation that includes an IL-31 antagonist as an active ingredient, along with arginine and/or a salt thereof and sucrose and/or trehalose. Additionally, he has developed solution formulations that also contain an IL-31 antagonist and arginine. His work emphasizes methods for stabilizing antibodies, suppressing aggregation, and reducing charge heterogeneity in antibody formulations.

Career Highlights

So Yamaguchi is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His innovative research has positioned him as a key figure in the development of advanced therapeutic solutions. His expertise in antibody formulations has contributed to the advancement of biopharmaceutical technologies.

Collaborations

Yamaguchi has collaborated with notable colleagues, including Daisuke Kameoka and Toru Yoshizawa. These partnerships have fostered a collaborative environment that enhances the innovation process within their projects.

Conclusion

So Yamaguchi's contributions to the field of antibody formulations demonstrate his commitment to advancing biopharmaceutical research. His innovative patents and collaborations highlight his role as a leading inventor in this critical area of healthcare.